$1.32 +0.02 (%) Infinity Pharmaceuticals Inc - NASDAQ

Jun. 24, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Mid-Afternoon Market Update: Crude Oil Slides Over 2%; MannKind Shares Dip On Termination Of Afrezza Deal With Sanofi

    Benzinga | Jan. 5, 2016 | 15:07PM EST
  2. Infinity Announces Enrollment Of 120th Patient In Phase 2 DYNAMO™ Study Evaluating Duvelisib In Indolent Non-Hodgkin Lymphoma

    Benzinga | Sep. 30, 2015 | 09:03AM EST
  3. A Portfolio To Support Cancer Treatments In Time For Prostate Cancer Awareness Month

    Benzinga | Sep. 8, 2015 | 16:05PM EST
  4. Benzinga's Top Initiations

    Benzinga | May. 7, 2015 | 10:03AM EST
  5. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  6. JPM Securities Picks Through Biotech News For Winners

    Benzinga | Feb. 25, 2015 | 12:41PM EST
  7. UPDATE: Infinity Pharmaceuticals Posts Q4 Loss

    Benzinga | Feb. 24, 2015 | 17:41PM EST
  8. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  9. Morning Market Losers

    Benzinga | Jan. 8, 2015 | 09:54AM EST
  10. Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday Morning

    Benzinga | Jan. 8, 2015 | 09:00AM EST
  11. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 8, 2015 | 08:22AM EST
  12. Infinity Announces Clinical And Preclincal Data For Duvelisib To Be Presented at ASH 2014 Annual Meeting

    Benzinga | Nov. 6, 2014 | 09:06AM EST
  13. Infinity Reports Topline Data From Phase 2a Exploratory Study Of Duvelisib In Patients With Mild, Allergic Asthma

    Benzinga | Oct. 16, 2014 | 07:35AM EST
  14. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga | Sep. 22, 2014 | 12:59PM EST
  15. Pharmacyclics Price Target Cut On Higher Spending

    IBD | Sep. 8, 2014 | 13:02PM EST
  16. Benzinga's Top Upgrades

    Benzinga | Sep. 4, 2014 | 09:11AM EST
  17. JMP Securities Upgrades Infinity Pharmaceuticals To Market Outperform

    Benzinga | Sep. 4, 2014 | 07:04AM EST
  18. Infinity, AbbVie team on drug

    IBD | Sep. 3, 2014 | 18:36PM EST
  19. S&P 500 Struggles To Hold 2,000 As Commodities Rebound

    Benzinga | Sep. 3, 2014 | 17:01PM EST
  20. Midday Gainers From Wednesday, September 3

    Benzinga | Sep. 3, 2014 | 14:41PM EST
  21. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD | Sep. 3, 2014 | 13:20PM EST
  22. NASDAQ Tumbles 0.5%; Infinity Pharmaceuticals Jumps On Deal With AbbVie

    Benzinga | Sep. 3, 2014 | 13:01PM EST
  23. Markets Gain; Toll Brothers Profit Beats Estimates

    Benzinga | Sep. 3, 2014 | 11:22AM EST
  24. Benzinga's Volume Movers

    Benzinga | Sep. 3, 2014 | 10:27AM EST
  25. Morning Market Movers

    Benzinga | Sep. 3, 2014 | 09:43AM EST
  26. Stock Futures Up And Climbing; Baidu Heads China Stock Rally

    IBD | Sep. 3, 2014 | 09:08AM EST
  27. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 3, 2014 | 08:04AM EST
  28. What You Need to Know About the Roche-InterMune Deal

    Benzinga | Aug. 29, 2014 | 15:51PM EST
  29. Markets Open Higher; Burger King In Talks To Buy Tim Hortons

    Benzinga | Aug. 25, 2014 | 11:41AM EST
  30. InterMune's Roche Deal Sends Peer Group Up

    Benzinga | Aug. 25, 2014 | 11:38AM EST
  31. 3 Small-Cap Biotechs That Institutions Are Loving

    Benzinga | Jul. 7, 2014 | 14:54PM EST
  32. UPDATE: Morgan Stanley Initiates Coverage On Infinity Pharmaceuticals On Data Upside Driver

    Benzinga | Jun. 25, 2014 | 09:40AM EST
  33. The Top Five Drug Launches Of 2013

    IBD | Dec. 31, 2013 | 13:42PM EST
  34. UPDATE: Credit Suisse Downgrades Infinity Pharmaceuticals on Limited Clinical News in 2014

    Benzinga | Dec. 12, 2013 | 09:02AM EST
  35. Benzinga's Top Downgrades

    Benzinga | Dec. 12, 2013 | 07:29AM EST
  36. Celgene's stock hits new high

    IBD | Dec. 9, 2013 | 18:46PM EST
  37. Mid-Day Market Update: Sysco Shares Rise Following Merger with US Foods; McDonald's Falls

    Benzinga | Dec. 9, 2013 | 12:39PM EST
  38. Celgene, Infinity Rise On Blood Cancer Drug Data

    IBD | Dec. 9, 2013 | 11:24AM EST
  39. Benzinga's Volume Movers

    Benzinga | Dec. 9, 2013 | 10:34AM EST
  40. Infinity Reports Encouraging Phase 1 IPI-145 Data at ASH

    Benzinga | Dec. 8, 2013 | 10:35AM EST
  41. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ASH

    Benzinga | Dec. 7, 2013 | 11:16AM EST
  42. Infinity Announces Updated Phase 1 Data of IPI-145 in iNLH at ASH 2013

    Benzinga | Dec. 7, 2013 | 11:16AM EST
  43. UPDATE: William Blair Initiates Coverage on Infinity Pharmaceuticals on Multiple Challenges Ahead

    Benzinga | Sep. 24, 2013 | 10:55AM EST
  44. Benzinga's Top Initiations

    Benzinga | Sep. 24, 2013 | 07:44AM EST
  45. The Best Small Cap Performers of 2012

    Benzinga | Dec. 27, 2012 | 09:36AM EST
  46. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 24, 2012 | 03:07AM EST
  47. Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma

    Benzinga | Dec. 24, 2012 | 01:09AM EST
  48. Infinity Announces Amended PI3K-Delta,Gamma Agreement with Millennium

    Benzinga | Dec. 24, 2012 | 01:09AM EST
  49. Infinity Announces Closing of Public Offering and Exercise of Over-Allotment Option

    Benzinga | Dec. 18, 2012 | 03:26AM EST
  50. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 14, 2012 | 03:15AM EST
Trading Center